Sher, T., Ailawadhi, S., Miller, K. C., Manfredi, D., Wood, M., Tan, W., . . . Chanan-Khan, A. (2011). A steroid-independent regimen of bortezomib, liposomal doxorubicin and thalidomide demonstrate high response rates in newly diagnosed multiple myeloma patients.
Citação norma ChicagoSher, Taimur, et al. A Steroid-independent Regimen of Bortezomib, Liposomal Doxorubicin and Thalidomide Demonstrate High Response Rates in Newly Diagnosed Multiple Myeloma Patients. 2011.
Citação norma MLASher, Taimur, et al. A Steroid-independent Regimen of Bortezomib, Liposomal Doxorubicin and Thalidomide Demonstrate High Response Rates in Newly Diagnosed Multiple Myeloma Patients. 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.